Wintrust Investments’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-188
| Closed | -$27K | – | 468 |
|
|
2024
Q3 | $27K | Sell |
188
-1,694
| -90% | -$245K | 0.02% | 426 |
|
|
2024
Q2 | $258K | Sell |
1,882
-520
| -22% | -$69.4K | 0.02% | 406 |
|
|
2024
Q1 | $330K | Sell |
2,402
-490
| -17% | -$66.9K | 0.03% | 353 |
|
|
2023
Q4 | $393K | Sell |
2,892
-199
| -6% | -$24.3K | 0.04% | 311 |
|
|
2023
Q3 | $378K | Buy |
3,091
+95
| +3% | +$12.1K | 0.04% | 300 |
|
|
2023
Q2 | $380K | Sell |
2,996
-150
| -5% | -$19.5K | 0.04% | 295 |
|
|
2023
Q1 | $406K | Buy |
3,146
+334
| +12% | +$43.7K | 0.05% | 233 |
|
|
2022
Q4 | $369K | Hold |
2,812
| – | – | 0.05% | 260 |
|
|
2022
Q3 | $329K | Sell |
2,812
-24
| -0.8% | -$2.98K | 0.04% | 290 |
|
|
2022
Q2 | $334K | Sell |
2,836
-450
| -14% | -$53.4K | 0.04% | 287 |
|
|
2022
Q1 | $428K | Buy |
3,286
+199
| +6% | +$25.9K | 0.04% | 270 |
|
|
2021
Q4 | $471K | Sell |
3,087
-148
| -5% | -$22.9K | 0.04% | 271 |
|
|
2021
Q3 | $523K | Sell |
3,235
-459
| -12% | -$77.2K | 0.07% | 175 |
|
|
2021
Q2 | $605K | Buy |
3,694
+608
| +20% | +$93.7K | 0.06% | 238 |
|
|
2021
Q1 | $465K | Buy |
+3,086
| New | +$490K | 0.05% | 269 |
|
|
2020
Q4 | – | Sell |
-3,131
| Closed | -$424K | – | 260 |
|
|
2020
Q3 | $424K | Sell |
3,131
-151
| -5% | -$20.5K | 0.06% | 219 |
|
|
2020
Q2 | $449K | Sell |
3,282
-279
| -8% | -$35.6K | 0.06% | 212 |
|
|
2020
Q1 | $384K | Sell |
3,561
-186
| -5% | -$21.4K | 0.06% | 208 |
|
|
2019
Q4 | $452K | Sell |
3,747
-109
| -3% | -$12.2K | 0.06% | 219 |
|
|
2019
Q3 | $384K | Buy |
3,856
+1
| +0% | +$105 | 0.06% | 242 |
|
|
2019
Q2 | $421K | Sell |
3,855
-599
| -13% | -$63.7K | 0.06% | 225 |
|
|
2019
Q1 | $498K | Sell |
4,454
-470
| -10% | -$51.6K | 0.08% | 202 |
|
|
2018
Q4 | $475K | Sell |
4,924
-1,066
| -18% | -$113K | 0.09% | 189 |
|
|
2018
Q3 | $730K | Buy |
5,990
+2,142
| +56% | +$252K | 0.12% | 161 |
|
|
2018
Q2 | $423K | Buy |
3,848
+1,785
| +87% | +$191K | 0.07% | 231 |
|
|
2018
Q1 | $220K | Sell |
2,063
-331
| -14% | -$36.7K | 0.06% | 236 |
|
|
2017
Q4 | $256K | Buy |
2,394
+93
| +4% | +$9.94K | 0.06% | 246 |
|
|
2017
Q3 | $256K | Sell |
2,301
-60
| -3% | -$6.41K | 0.06% | 239 |
|
|
2017
Q2 | $244K | Buy |
+2,361
| New | +$233K | 0.06% | 257 |
|
|
2016
Q4 | – | Sell |
-3,714
| Closed | -$358K | – | 233 |
|
|
2016
Q3 | $358K | Sell |
3,714
-1,893
| -34% | -$180K | 0.17% | 118 |
|
|
2016
Q2 | $81K | Buy |
+5,607
| New | +$503K | 0.16% | 48 |
|
Other funds holding IBB
Wintrust Investments's IBB Position: Q4 2024 in Review
Wintrust Investments sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 188 shares — an estimated $27K sold.
Wintrust Investments first reported a position in IBB in Q2 2016 and held it in 31 quarters. The position peaked at $730K in Q3 2018. 877 funds tracked by Wall St. Rank hold IBB as of Q4 2024.
- Wintrust Investments reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
- Wintrust Investments sold 188 iShares Biotechnology ETF shares in Q4 2024, an estimated $27K.
- Wintrust Investments first reported a position in iShares Biotechnology ETF in Q2 2016 and held it in 31 quarters.
- Wintrust Investments's iShares Biotechnology ETF position peaked at $730K in Q3 2018.
- 877 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.
Based on Wintrust Investments's 13F filing for Q4 2024, filed 10 Feb 2025.